home > drugs a-z list > bexxar (tositumomab and iodine 1131 tositumomab) drug center

Recommended Topic Related To:

Bexxar

Non-Hodgkin's lymphoma facts

  • NHL is a cancer that originates in the lymphatic system.
  • About 66,000 patients are diagnosed yearly, and approximately 18,000 patients die of NHL yearly in the U.S.
  • There are several subtypes of NHL, each requiring different treatments.
  • Symptoms include swollen lymph nodes, weight loss, fever, and night sweats.
  • NHL is staged on a 1-4 scale with A (no associated symptoms like fever, weight loss, or night sweats) and B subtypes.
  • Staging the cancer is important to determine treatment and predict the outcome of treatment.
  • Depending on the stage and type of NHL, treatment can include chemotherapy, biological therapy, stem cell transplant, and/or radiation therapy.

What is non-Hodgkin's lymphoma?

Non-Hodgkin's lymphoma is a type of cancer that originates in the lymphatic system. It is estimated to be the sixth most common cancer in the Unite...

Bexxar

font size

Bexxar Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Bexxar Prescribing Information: Indications & Dosage

Relapsed or Refractory CD20-Positive, Non-Hodgkin's Lymphoma

The BEXXAR® therapeutic regimen (tositumomab and iodine I 131 tositumomab) is indicated for the treatment of patients with CD20-positive relapsed or refractory, low grade, follicular, or transformed non-Hodgkin's lymphoma, including patients with rituximab-refractory non-Hodgkin's lymphoma.

Determination of the effectiveness of the BEXXAR therapeutic regimen is based on overall response rates. The effects of the BEXXAR therapeutic regimen on survival are not known.

Important Limitations of ...

Read the complete drug monograph for Bexxar »

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Bexxar Patient Information: Side Effects

Some people receiving tositumomab have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregivers right away if you feel dizzy, nauseated, light-headed, sweaty, or short of breath, or if you have fever or chills during the injection.

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

  • pale skin, easy bruising or bleeding, unusual weakness;
  • ...

Read the complete patient information for Bexxar »

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.